Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $18.3 Million - $32.9 Million
-442,500 Reduced 99.3%
3,100 $130,000
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $20.6 Million - $27 Million
365,600 Added 457.0%
445,600 $30.8 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $4.72 Million - $6.06 Million
80,000 New
80,000 $5.92 Million
Q2 2022

Aug 12, 2022

SELL
$35.61 - $76.23 $548,394 - $1.17 Million
-15,400 Reduced 92.77%
1,200 $47,000
Q2 2021

Sep 13, 2021

BUY
$93.66 - $139.27 $1.55 Million - $2.31 Million
16,600 New
16,600 $2.06 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.8B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.